Difference between revisions of "Stomach"

Line 814:

CK7 +ve.

CK20 -ve, occasionally +ve.

===Molecular===

*May have HER2 over expression - more common in intestinal-type tumours.<ref name=pmid22213295>{{Cite journal | last1 = Romiti | first1 = A. | last2 = Di Rocco | first2 = R. | last3 = Milione | first3 = M. | last4 = Ruco | first4 = L. | last5 = Ziparo | first5 = V. | last6 = Zullo | first6 = A. | last7 = Duranti | first7 = E. | last8 = Sarcina | first8 = I. | last9 = Barucca | first9 = V. | title = Somatostatin receptor subtype 2 A (SSTR2A) and HER2 expression in gastric adenocarcinoma. | journal = Anticancer Res | volume = 32 | issue = 1 | pages = 115-9 | month = Jan | year = 2012 | doi = | PMID = 22213295 }}</ref>

**Poor prognosis - like in breast cancer.

**Scoring system different than in breast cancer - complete membrane staining is not required.

=See also=

Difference between revisions of "Stomach"

Navigation menu

Search

@@ Line 814: / Line 814: @@
 CK7 +ve.
 CK20 -ve, occasionally +ve.
+===Molecular===
+*May have HER2 over expression - more common in intestinal-type tumours.<ref name=pmid22213295>{{Cite journal  | last1 = Romiti | first1 = A. | last2 = Di Rocco | first2 = R. | last3 = Milione | first3 = M. | last4 = Ruco | first4 = L. | last5 = Ziparo | first5 = V. | last6 = Zullo | first6 = A. | last7 = Duranti | first7 = E. | last8 = Sarcina | first8 = I. | last9 = Barucca | first9 = V. | title = Somatostatin receptor subtype 2 A (SSTR2A) and HER2 expression in gastric adenocarcinoma. | journal = Anticancer Res | volume = 32 | issue = 1 | pages = 115-9 | month = Jan | year = 2012 | doi =  | PMID = 22213295 }}</ref>
+**Poor prognosis - like in breast cancer.
+**Scoring system different than in breast cancer - complete membrane staining is not required.
 =See also=